Compare WKSP & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WKSP | CELZ |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0M | 7.5M |
| IPO Year | 2015 | 2008 |
| Metric | WKSP | CELZ |
|---|---|---|
| Price | $0.44 | $0.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 227.9K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.89 | 32.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,101,738.00 | $6,000.00 |
| Revenue This Year | $131.96 | N/A |
| Revenue Next Year | $24.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 89.78 | N/A |
| 52 Week Low | $0.37 | $0.62 |
| 52 Week High | $3.90 | $6.25 |
| Indicator | WKSP | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 33.45 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $0.77 | N/A |
| Average True Range (ATR) | 0.04 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 26.81 | 0.00 |
Worksport Ltd designs, develops, and manufactures products for markets including automotive accessories, consumer electronics, and residential and commercial HVAC systems. The company leverages a growing intellectual property portfolio of patents, designs, and trademarks covering products such as tonneau covers, solar-integrated tonneau covers, portable power stations, hydrogen-based green energy systems, heat pumps, and EV charging solutions. Its segments include soft tonneau covers, consisting mainly of vinyl-wrapped tri-fold and quad-fold covers manufactured by third-party suppliers, and hard tonneau covers, which generate the majority of revenue in the United States and include aluminum tri-fold and quad-fold covers manufactured and assembled in the United States.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.